Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Ketotifen Fumarate (Systemic)
Trade Name
Profilar
Manufacturer
UPM
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • Antiallergic, for asthma prophylaxis.
  • Fetal Risk
    Fetal Risk
  • Crosses placenta in animals.
  • No teratogenic or embryolethal effects in animals have been reported but decreased maternal weight gain and total body weight was reported at high doses.
  • High doses throughout pregnancy resulted in decreased birth weight and postnatal survival in some animals.
  • No adequate human data.
  • Breast Feeding
    Breast Feeding
  • Excreted into milk of lactating animals, may be excreted into human milk.
  • Breast feeding is not recommended during therapy.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     8   +   8    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year